Apostle Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 16
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $3.33M
Latest Deal Amount
  • Investors
  • 8

Apostle General Information

Description

Developer of a nano diagnostics technology designed to improve the efficiency and accuracy of liquid biopsy in early cancer detection. The company's technology leverages artificial intelligence to identify symptoms of cancer at an early stage in an accurate way through non-invasive prenatal tests, enabling doctors to take effective surgical actions within time.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 160 East Tasman Drive
  • Suite 116
  • San Jose, CA 95134
  • United States
+1 (888) 000-0000

Apostle Timeline

2018201920202021
Date FoundedFinancing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Apostle Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 05-Jun-2019 $3.33M 00.000 000.00 Completed Generating Revenue
3. Accelerator/Incubator 01-Apr-2018 00.000 Completed Startup
2. Grant 01-Sep-2017 $50K $2.35M Completed Startup
1. Seed Round 03-Apr-2017 $2.35M $2.35M 00.000 Completed Startup
To view Apostle’s complete valuation and funding history, request access »

Apostle Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 0,000,000 00.000000 00 00 00 00 000
To view Apostle’s complete cap table history, request access »

Apostle Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a nano diagnostics technology designed to improve the efficiency and accuracy of liquid biopsy in early can
Diagnostic Equipment
San Jose, CA
16 As of 2021
00.000
00.00 0000-00-00
00000000000 00.000

00000000

lor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magn
0000000000000
Carlsbad, CA
000 As of 0000
000.00
000000&0 000.00

00000

a aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
0000000000000
Menlo Park, CA
000 As of 0000
000
00 0000-00-00
000000&0 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Apostle Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Autogenomics Formerly VC-backed Carlsbad, CA 000 000.00 000000&0 000.00
00000 Formerly VC-backed Menlo Park, CA 000 000 000000&0 000
0000000 Venture Capital-Backed Irvine, CA 000 00000 000000000 - 00000
0000000000 0000000 Formerly VC-backed Cambridge, MA 0000 00000 00000000000
0000000 Venture Capital-Backed Menlo Park, CA 00 0000 00000000000 0000
You’re viewing 5 of 24 competitors. Get the full list »

Apostle Patents

Apostle Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3704640-A4 Predicting cancer-related pathogenic impact of somatic mutations using deep learning-based methods Pending 27-Oct-2017 0000000000 0
EP-3704640-A1 Predicting cancer-related pathogenic impact of somatic mutations using deep learning-based methods Pending 27-Oct-2017 000000000
US-20200342955-A1 Predicting cancer-related pathogenic impact of somatic mutations using deep learning-based methods Pending 27-Oct-2017 000000000
EP-3645767-A1 Magnetic nanoparticle Pending 30-Jun-2017 000000000000
US-20200124592-A1 Magnetic nanoparticle Pending 30-Jun-2017 G01N33/54326

Apostle Executive Team (5)

Name Title Board Seat Contact Info
David Ge MD Chief Executive Officer, President & Board Member
Wenqi Zeng MD Senior Vice President of Medicine, Chief Medical Advisor & Board Member
Xin Guo Ph.D Co-Founder, Vice President of Bioinformatics & Board Member
Eric Masingale Vice President
You’re viewing 4 of 5 executive team members. Get the full list »

Apostle Board Members (5)

Name Representing Role Since
David Ge MD Apostle Chief Executive Officer, President & Board Member 000 0000
Wenqi Zeng MD Apostle Senior Vice President of Medicine, Chief Medical Advisor & Board Member 000 0000
William Dai ShangBay Capital Board Member 000 0000
Xin Guo Ph.D Apostle Co-Founder, Vice President of Bioinformatics & Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Apostle Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Apostle Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aethan Capital Other Minority 000 0000 000000 0
StartX (US) Not-For-Profit Venture Capital Minority 000 0000 000000 0
Alibaba Cloud Computing Corporation 000 0000 000000 0
Amino Capital Venture Capital Minority 000 0000 000000 0
GEM Tech Ventures Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »